Search Results - "Arambam, P."

Experience with PCI in CKD patient (disease pattern, immediate and short term outcome) by Doomra, M, Tiwari, S.C, Sandhu, P.S, Arambam, P, Kaul, U

Get full text

A multicentric, retrospective, outcome analysis of contemporary antiplatelet discontinuation practices in coronary artery disease patients undergoing cardiac / non cardiac surgeries by Arambam, P, Kaul, U, Gandrota, D, Shekhawat, S

Get full text

Paclitaxel-eluting stent (PES) versus everolimus-eluting stent (EES) in insulin requiring diabetics – Are the results different? by Kaul, U, Abhaychand, R, Patel, T, Banker, D, Abhyankar, A, Mullasari, A, Shah, S, Jain, R, Kumar, P, Bahuleyan, C.G, Arambam, P

Get full text

Paclitaxel-eluting versus everolimus-eluting stents in patients with diabetes mellitus and coronary artery disease (TUXEDO India Study) by Kaul, U, Abhaychand, R, Patel, T, Banker, D, Abhyankar, A, Mullasari, A, Shah, S, Jain, R, Kumar, P, Bahuleyan, C.G, Arambam, P

Get full text

Safety of Prasugrel in Indian patients – Multicentric registry of 1000 cases by Kaul, Upendra, Sethi, Arvind, Arambam, P, Omar, A.K, Keshava, R, Roy, Sanjeeb, Ray, Shuvanan, Jaswal, Rakesh, Gupta, Ripan K, Sapra, Rakesh Rai, Keshav, Rane Sandip, Singh, Rajpal, Bhatia, Vineet, Sanghi, Vinay, Chopra, Arun

“…Abstract Background Clopidogrel has been the only available antiplatelet drug used along with aspirin in patients of ACS. In recent years 2 new antiplatelet…”
Get full text

Thirty day outcomes of Indian patients in a multicenteric hospital registry of patients with acute coronary syndrome (ACS) undergoing PCI treated with prasugrel by Omar, A, Gupta, R, Keshava, R, Ray, S, Roy, S, Jaswal, R, Sapra, R, Arambam, P, Kaul, U, Seth, A

Get full text

India Heart Study – IHS by Kaul, U., Verberk, W., Suvarna, V., Wander, G.S., Vishwanathan, M., Dani, S., Hiremath, J., Alegesan, R., Vaidyanathan, P.R., Natarajan, S., Chandwani, P., Punrnanad, A., Nair, T., Kapoor, S., Kumar, S., Arambam, P.

Get full text